ANZITH-500
Azithromycin 500 mg
Azithromycin
- Highly active against multiple organisms including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Chlamydia trachomatis.
- Possesses long half-life leading to once-daily dose convenience. (Curr. ther. Res.;2003, vol. 64 (29 ref.), pp. A30-A42)
- Improves lung function and increases weight in cystic fibrosis.
- Achieves superior clinical cure rates compared to Clarithromycin in chronic bronchitis.
Indications:
- LRTI
- Acute & Chronic Bronchitis
- Community Acquired Pneumonia
- Acute exacerbation of COPD (Treat Respir Med. 2005; 4(1):31-9)
- URTI
- Otitis Media
- Acute & Chronic Sinusitis
- Tonsillitis & Pharyngitis
Perfect Defense Against Tough Infections. Safe choice in infection.
